Named as a key player in 33 of our reports, across 33 regions and countries.
Our reports that name Genome Medical as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Genome Medical (number of shared markets).
Myriad Genetics, Inc.1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
0 active studies led by Genome Medical, of 4 in all
Source: ClinicalTrials.gov, Studies with Genome Medical (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Genome Medical leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Genome Medical or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
The topics of the markets Genome Medical is in.